SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-013588
Filing Date
2023-05-10
Accepted
2023-05-10 16:07:10
Documents
63
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q arav20230331_10q.htm   iXBRL 10-Q 824469
2 EXHIBIT 31.1 ex_473281.htm EX-31.1 12053
3 EXHIBIT 31.2 ex_473282.htm EX-31.2 12077
4 EXHIBIT 32.1 ex_473283.htm EX-32.1 5433
5 EXHIBIT 32.2 ex_473284.htm EX-32.2 5457
  Complete submission text file 0001437749-23-013588.txt   4685882

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA arav-20230331.xsd EX-101.SCH 49985
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arav-20230331_cal.xml EX-101.CAL 25759
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20230331_def.xml EX-101.DEF 309494
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20230331_lab.xml EX-101.LAB 285711
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20230331_pre.xml EX-101.PRE 334685
57 EXTRACTED XBRL INSTANCE DOCUMENT arav20230331_10q_htm.xml XML 660123
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 23906350
SIC: 2834 Pharmaceutical Preparations